Dossier Skeleton and Document Checklist for Myanmar

1. Key takeaways

A Myanmar medical device registration dossier is built around eight categories of core documents: (1) a letter of authorisation from the foreign manufacturer; (2) a free sale or export certificate from the country of origin; (3) a manufacturing licence or GMP certificate; (4) an ISO certificate; (5) a manufacturing flow chart; (6) the sterilization method, where applicable; (7) a certificate of analysis for the product sample; and (8) the business licence or company registration certificate of the local authorised representative. The competent authority may additionally require further documents and information depending on the product.

GRZAN note: the completeness of this list is the precondition for passing the formal (administrative) review, while internal consistency is the precondition for passing the technical review. When preparing the dossier, companies should build two working tools at the same time: a deficiency checklist and a cross-document consistency matrix. The dossier structure can be remembered as 8 categories of core documents, grouped into 3 sets, plus 1 flexible catch-all clause.

• Letter of authorisation issued by the foreign manufacturer;
• Free sale or export certificate issued in the country of origin;
• Manufacturing licence or GMP certificate;
• ISO certificate;
• Manufacturing flow chart;
• Sterilization method, where applicable (sterile products only);
• Certificate of analysis for the product sample;
• Business licence or company registration certificate of the local authorised representative.

In practice the two review gates test different things. The formal review asks whether every item on the list is present and formally valid; the technical review asks whether the documents that are present actually agree with one another. A dossier that is complete but inconsistent can therefore fail at the second gate even after passing the first, which is why both tools should be maintained throughout preparation rather than assembled at the end.

2. Legal basis

The eight-category list, the flexible catch-all clause and the applicable quality management system are summarised below. The listing distinguishes between documents that are always required and the sterilization file, which is conditional on the supply status of the product. The applicable quality management system is ISO 13485.

3. Expert insights

Insight 1: the eight documents can be grouped into three sets — entity qualification, product technology and quality evidence. Documents (1), (2) and (8) belong to entity qualification; documents (5) and (6) belong to product technology; documents (3), (4) and (7) belong to quality evidence. Understanding the grouping makes it possible to prepare the three sets in parallel and to assign clear internal responsibility for each of them, so that a delay in one stream does not silently block the others.

Insight 2: the flexible clause means the published list is a minimum requirement, not an exhaustive one. The authority explicitly states that the Myanmar FDA may stipulate additional documents and information. When scheduling the project, companies must therefore never assume that the eight categories are all that will ever be asked for; extra requests are a normal planning scenario, not an exception, and the submission calendar should absorb them without renegotiating the launch date.

Insight 3: document 7, the certificate of analysis, targets the product sample. This requirement binds documentary evidence to a physical batch. Companies must make sure that the sample submitted for testing comes from the same product family as the batches intended for sale, so that the analytical result actually describes what will be placed on the Myanmar market rather than an unrepresentative pilot lot.

Insight 4: document 6, the sterilization method, is a conditional requirement. It applies only to sterile products. Companies must first determine whether their product is supplied sterile, and only then decide whether this document has to be prepared and submitted. This determination should be recorded explicitly in the project file so that the decision is auditable later.

Insight 5: documents 2, 3 and 4 cross-validate each other. The free sale certificate, the manufacturing licence and the ISO certificate must be consistent with one another in product name, model designation and manufacturer information. Any mismatch between these three certificates is an obvious target for reviewers and an avoidable cause of deficiency letters, and it is best caught during internal review rather than by the authority.

4. Practical recommendations

• Build a deficiency checklist based on the eight document categories. Confirm every item before submission and leave no blank fields.
• Maintain a cross-document consistency matrix. Focus the comparison on product name, model designation and address fields across all certificates.
• Reserve time and budget for additional documents under the flexible clause. Prepare contingency plans for plausible supplementary requests.
• Ensure the tested sample matches the batches intended for sale. Keep sample batch records that link the tested unit to commercial lots.
• Apply the conditional-requirement logic to the sterilization file. Neither submit it blindly nor omit it by mistake.

5. Verification checklist

• □ Letter of authorisation prepared and signed by the foreign manufacturer
• □ Free sale or export certificate obtained from the country of origin
• □ Manufacturing licence or GMP certificate obtained
• □ ISO certificate obtained
• □ Manufacturing flow chart prepared
• □ Sterilization method description prepared for sterile products
• □ Certificate of analysis for the product sample obtained
• □ Business licence or company registration certificate of the local authorised representative obtained
• □ Cross-document consistency matrix established
• □ Time and budget reserved for additional documents under the flexible clause

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support across Southeast Asia, including Myanmar. Our team prepares the technical dossier to ASEAN CSDT structure, manages submission and deficiency responses with the Myanmar FDA, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com